Kanvas Biosciences Acquires 2 Active Therapeutics Programmes from Federation Bio to Accelerate Immuno-Oncology Programme.

MANews-(C)2009-2023

US-based microbiome mapping technology company Kanvas Biosciences has acquired two active therapeutics programmes, a microbial library, and intellectual property from California-based live biotherapeutics products manufacturer Federation Bio, the company said.

Terms of the transaction were not disclosed.

This acquisition transitions Kanvas Biosciences from a technology company with a transformative spatial biology platform to a full-stack therapeutics company with active clinical programmes and a new cell banking facility in South San Francisco.

The deal expands the company's leadership and West Coast presence with the addition of Lee Swem, formerly Federation Bio's chief science officer, who joined Kanvas Biosciences as Chief Development officer.

The microbiome plays a critical role in either improving or exacerbating a broad range of...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT